Avidity Biosciences, Inc.

NASDAQ:RNA

50.36 (USD) • At close September 5, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 3.8471.5732.9732.3362.0453.5432.1932.8182.3162.2332.7692.4822.1781.7951.8522.1632.6072.7042.1421.7461.5411.3581.4450.650.2240
Kosten van de omzet 0.814000.710.6870.6410.615-0.8541.2611.0790.3810.439.7890.3140.20824.83122.70620.67713.6199.4558.9845.5445.6455.0992.5331.262
Brutowinst 3.0331.5732.9732.3361.3582.9021.5783.6721.0551.1542.3882.082-37.6111.4811.644-22.668-20.099-17.973-11.477-7.709-7.443-4.186-4.2-4.449-2.309-1.262
Brutowinstmarge 0.7881110.6640.8190.721.3030.4560.5170.8620.839-17.2690.8250.888-10.48-7.71-6.647-5.358-4.415-4.83-3.082-2.907-6.845-10.3080
Onderzoek- en ontwikkelingskosten 138.12599.4995.62577.19763.9466.83252.81747.71442.67247.76545.6137.31739.78927.68832.96824.83122.70620.67713.6199.4558.9845.5445.6455.0992.5331.262
Algemene en administratieve kosten 36.86433.628.33823.27320.73113.89816.11913.72912.27812.06410.38410.0948.6888.5677.4316.6126.2685.8844.8163.7572.9251.9641.8470.7571.5960.912
Verkoop- en marketingkosten 00000-0.641-0.6150000000000000000000
Verkoop-, algemene en administratieve kosten 36.86433.628.33823.27320.73113.25715.50413.72912.27812.06410.38410.0948.6888.5677.4316.6126.2685.8844.8163.7572.9251.9641.8470.7571.5960.912
Overige kosten 0000-0.68700-1.3-0.1625.2020-0.012-0.002-0.0250.009-0.011-0.002-0.0030.0180000000
Bedrijfskosten 174.989133.09123.963100.4783.98480.08968.32160.14354.9559.82955.99447.41148.47736.25540.39931.44328.97426.56118.43513.21211.9097.5087.4925.8564.1292.174
Bedrijfsresultaat -171.142-131.517-120.99-98.134-82.626-77.187-66.743-58.625-52.634-52.785-53.225-44.929-46.299-34.46-38.547-29.28-26.367-23.857-16.293-11.466-10.368-6.15-6.047-5.206-3.905-2.174
Bedrijfsresultaat ratio -44.487-83.609-40.696-42.009-40.404-21.786-30.435-20.804-22.726-23.639-19.222-18.102-21.258-19.198-20.814-13.537-10.114-8.823-7.606-6.567-6.728-4.529-4.185-8.009-17.4330
Totaal overige inkomsten en kosten netto 13.82715.74418.73317.73611.8338.3326.36.2675.6095.2022.7541.330.6090.2250.0090.0060.0140.0130.0180.027-0.1880.065-4.354-1.462-1.211-0.375
Inkomen voor belasting -157.315-115.773-102.257-80.398-70.793-68.855-60.443-52.358-47.025-52.394-50.471-43.599-45.69-34.235-38.538-29.274-26.353-23.844-16.275-11.439-10.556-6.085-10.401-6.668-5.116-2.549
Inkomen voor belasting ratio -40.893-73.6-34.395-34.417-34.618-19.434-27.562-18.58-20.304-23.464-18.227-17.566-20.978-19.072-20.809-13.534-10.109-8.818-7.598-6.552-6.85-4.481-7.198-10.258-22.8390
Belastingkosten 000000000-5.202-2.754-1.330-0.225-0.009-0.006-0.014-0.013-0.018-0.027000000
Nettowinst -157.315-115.773-102.257-80.398-70.793-68.855-60.443-52.358-47.025-47.192-47.717-42.269-45.69-34.01-38.529-29.274-26.353-23.844-16.275-11.439-10.556-6.085-10.401-6.668-5.116-2.549
Nettowinstmarge -40.893-73.6-34.395-34.417-34.618-19.434-27.562-18.58-20.304-21.134-17.233-17.03-20.978-18.947-20.804-13.534-10.109-8.818-7.598-6.552-6.85-4.481-7.198-10.258-22.8390
WPA (Winst Per Aandeel) -1.21-0.9-0.8-0.65-0.66-0.79-0.79-0.71-0.66-0.67-0.83-0.8-0.92-0.71-1.63-0.68-0.7-0.64-0.43-0.31-1.23-0.2-0.5-0.32-0.25-0.12
Verwaterde WPA -1.21-0.9-0.8-0.65-0.66-0.79-0.79-0.71-0.66-0.67-0.83-0.8-0.92-0.7-1.63-0.68-0.7-0.64-0.43-0.31-1.23-0.2-0.5-0.32-0.25-0.12
EBITDA -171.142-130.732-120.252-97.424-81.939-76.546-66.128-58.059-52.105-57.205-50.09-44.559-45.977-34.146-38.33-29.104-26.22-23.749-16.16-11.338-10.368-5.924-5.98-5.122-3.817-2.081
EBITDA ratio -44.487-83.11-40.448-41.705-40.068-21.605-30.154-20.603-22.498-25.618-18.09-17.953-21.11-19.023-20.697-13.455-10.058-8.783-7.544-6.494-6.728-4.362-4.138-7.88-17.040